Target intelligence / Profile preview

Renal proximal tubule endocytic reabsorption pathway

Molecular classification
Receptor, Transporter, Endocytic pathway
01

Overview

The renal proximal tubule endocytic reabsorption pathway is a specialized transport system located on the apical membrane of proximal tubule cells, primarily driven by the multiligand receptors Megalin (LRP2) and Cubilin (CUBN) (Christensen & Birn, 2002). Its primary biological function is the efficient recovery of low-molecular-weight proteins, vitamins, and hormones from the glomerular filtrate to prevent their excretion and maintain systemic homeostasis (Nielsen et al., 2016). This pathway is essential for the reabsorption of vital substances such as albumin, retinol-binding protein, and vitamin D-binding protein (Schuh et al., 2018). In clinical medicine, this pathway is a double-edged sword; it is the primary route for the nephrotoxic accumulation of drugs like aminoglycosides and polymyxins, which can lead to acute kidney injury (Moestrup & Verroust, 2001). However, it also presents a significant opportunity for targeted drug delivery, where therapeutic agents are conjugated to ligands that specifically bind Megalin or Cubilin to enhance renal uptake. Dysfunction of this pathway, often due to genetic mutations or secondary damage, results in tubular proteinuria and is a key feature of conditions like Fanconi syndrome and Dent disease (Nielsen et al., 2016).

Other names
Megalin-Cubilin pathwayReceptor-mediated endocytosis in the proximal tubuleApical endocytic complexLRP2-CUBN pathway
02

Mechanism of action

Ligand binding to Megalin (LRP2) and Cubilin (CUBN) receptors on the apical membrane, followed by clathrin-mediated endocytosis and subsequent lysosomal degradation or transcytosis.

03

Biological functions

Protein reabsorptionVitamin transportMetabolic homeostasisEndocytosisIon homeostasis
04

Disease associations

ProteinuriaFanconi syndromeChronic kidney diseaseNephrotoxicityDent diseaseLowe syndromeImerslund-Grasbeck syndrome
05

Safety considerations

Drug-induced nephrotoxicityLysosomal storage overloadCompetitive inhibition of essential nutrient reabsorptionAcute tubular necrosisAccumulation of radiopharmaceuticals
06

Interacting drugs

Gentamicin

9 more in the full profile.

07

Biomarkers

Urinary Retinol-Binding Protein 4 (RBP4)Urinary Alpha-1-Microglobulin (A1M)Urinary Beta-2-Microglobulin (B2M)Urinary Cystatin CUrinary Albumin

Beyond the preview

Go deeper on Renal proximal tubule endocytic reabsorption pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal proximal tubule endocytic reabsorption pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call